Market Overview

I think you’ll love what you hear,
what you’ll see and the opportunities
that will be set before you.
- Jon Najarian

ICON Launches FIRECREST Pre-Screen to Improve the Speed and Accuracy of Identifying Eligible Patients for Screening


FIRECREST Pre-Screen improves sponsor visibility of patient access

ICON plc, (NASDAQ:ICLR) a global provider of drug development
solutions and services to the pharmaceutical, biotechnology and medical
device industries, today announced the launch of FIRECREST Pre-Screen,
an innovative digital solution that increases the efficiency and quality
of initial patient eligibility assessments. FIRECREST Pre-Screen
provides a more robust solution for site personnel to identify
potentially eligible patients which can lead to improved enrolment rates
and reduced costs by preventing ineligible patients from progressing to
the full screening stage.

ICON has developed FIRECREST Pre-Screen to address the ongoing
industry challenge of patient recruitment, which can represent more than
30% of total study costs. ICON clinical trial experts work with study
clinicians to identify suitable eligibility criteria for pre-screen
assessments, and convert the criteria into a series of easy to
understand questions that are available to study personnel via the FIRECREST
Site Portal
. Each assessment is stored on the portal and study teams
can access aggregated data to view real-time pre-screen activity. This
increased transparency provides early insight into study criteria that
may be impacting patient recruitment.

"FIRECREST Pre-Screen supports site staff in identifying eligible
patients more efficiently while saving time and minimising site burden
and associated costs for the sponsor`," commented Mark Connolly, VP
FIRECREST at ICON. "It also minimises burden on patients by more
precisely identifying appropriate patients for full screening."

Site Portal
is a single sign-on, central hub for digital solutions,
including ICON's award winning GCP and Protocol Overview training
modules, Visit By Visit Guide and Trial Drive for the distribution and
tracking of study critical documents to sites. It also enables the
hosting of third party and sponsor training content with learning
management and compliance features.

To learn more about ICON's FIRECREST digital solutions, visit

About ICON plc

ICON plc is a global provider of drug development solutions and services
to the pharmaceutical, biotechnology and medical device industries. The
company specialises in the strategic development, management and
analysis of programs that support clinical development - from compound
selection to Phase I-IV clinical studies. With headquarters in Dublin,
Ireland, ICON currently, operates from 97 locations in 38 countries and
has approximately 13,100 employees..

Further information is available at


This press release contains forward-looking statements. These
statements are based on management's current expectations and
information currently available, including current economic and industry
conditions. These statements are not guarantees of future performance or
actual results, and actual results, developments and business decisions
may differ from those stated in this press release. The forward-looking
statements are subject to future events, risks, uncertainties and other
factors that could cause actual results to differ materially from those
projected in the statements, including, but not limited to, the ability
to enter into new contracts, maintain client relationships, manage the
opening of new offices and offering of new services, the integration of
new business mergers and acquisitions, as well as economic and global
market conditions and other risks and uncertainties detailed from time
to time in SEC reports filed by ICON, all of which are difficult to
predict and some of which are beyond our control. For these reasons, you
should not place undue reliance on these forward-looking statements when
making investment decisions. The word "expected" and variations of such
words and similar expressions are intended to identify forward-looking
statements. Forward-looking statements are only as of the date they are
made and we do not undertake any obligation to update publicly any
forward-looking statement, either as a result of new information, future
events or otherwise. More information about the risks and uncertainties
relating to these forward-looking statements may be found in SEC reports
filed by ICON, including its Form 20-F, F-1, S-8 and F-3, which are
available on the SEC's website at

View Comments and Join the Discussion!